FLR
65
9
CMA
65
7
CCI
18
-10
CCL
81
11
OI
55
3
AMG
66
3
BWA
52
-8
RSG
68
-2
UNH
17
2
MTB
75
6
HST
52
7
CLX
50
5
CAT
55
8
CVX
37
5
F
63
5
REGN
46
8
LRCX
74
10
RL
86
4
PVH
49
6
HSIC
59
3
FLR
65
9
CMA
65
7
CCI
18
-10
CCL
81
11
OI
55
3
AMG
66
3
BWA
52
-8
RSG
68
-2
UNH
17
2
MTB
75
6
HST
52
7
CLX
50
5
CAT
55
8
CVX
37
5
F
63
5
REGN
46
8
LRCX
74
10
RL
86
4
PVH
49
6
HSIC
59
3
Financhill
Back

Rigel Pharmaceuticals 10K Form

Sell
44

RIGL
Rigel Pharmaceuticals

Last Price:
$18.30
Seasonality Move:
-1.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-07 10Q RIGL/Rigel Pharmaceuticals Quarterly
2023-11-07 10Q RIGL/Rigel Pharmaceuticals Quarterly
2023-08-01 10Q RIGL/Rigel Pharmaceuticals Quarterly
2023-05-02 10Q RIGL/Rigel Pharmaceuticals Quarterly
2022-11-03 10Q RIGL/Rigel Pharmaceuticals Quarterly
2022-08-02 10Q RIGL/Rigel Pharmaceuticals Quarterly

Receive RIGL News And Ratings

See the #1 stock for the next 7 days that we like better than RIGL

RIGL Financial Statistics

Sales & Book Value

Annual Sales: $179.3M
Cash Flow: $-893K
Price / Cash Flow: 9.32
Annual Sales: $1.04
Price / Book: 17.91

Profitability

EPS (TTM): 2.07000
Net Income (TTM): $37.2M
Gross Margin: $160.6M
Return on Equity: 0%
Return on Assets: 25.32%

Rigel Pharmaceuticals Earnings Forecast

Key Rigel Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 26 years for RIGL is 89.60%.
  • The Selling, General & Administrative Expenses for RIGL have been equal to 63.06% of Gross Profit Margin.
  • The Research & Development expenses have been 13.04% of Revenue.
  • The Interest Expense is 45.28% of Operating Income.
  • The Net Earning history of RIGL is 9.75% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 18 years.

Rigel Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RIGL
CUSIP: 766559
Website: rigel.com

Debt

Debt-to-Equity Ratio: 3.22
Current Ratio: 2.2
Quick Ratio: 1.78

Price-to-Earnings

Trailing P/E Ratio: 18.8
Forward P/E Ratio: 9.38

RIGL Technical Analysis vs Fundamental Analysis

Sell
44
Rigel Pharmaceuticals (RIGL) is a Sell

Is Rigel Pharmaceuticals a Buy or a Sell?